Monday, March 17, 2025 | 09:01 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

EvolutionX Debt Capital makes maiden investment in PharmEasy parent firm

Debt financing platform's investment amount was not revealed; it will make equity infusion later

cash, fund, money, Rupee, growth, transaction, investment, sell, buy, market, acquisition, stake, share, stock, incentive
Premium

Aryaman Gupta New Delhi
EvolutionX Debt Capital, a growth-stage debt financing platform, has made its maiden investment in API Holdings, the parent company of PharmEasy, India’s largest online pharmacy.

The investment, of an undisclosed amount, is part of a sequence of planned capital raises and it will be followed by equity infusion in the company in the near-term, said Siddharth Shah, chief executive officer and co-founder of API Holdings.

“This collective capital raise will optimize the capital structure as well as improve the net debt position and financial strength of the company, ensuring a clear runway to profitability,” he said.

Capital markets are muted

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in